Skip to content
No picture yet

Qulipta 30 mg – DIN 02533987

Qulipta is Atogepant 30 mg (tablet), sold in Canada. It is used for migraine. It is supplied by Abbvie Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Atogepant 30 mg

Brand
Qulipta
Strength
30 mg
Used for
Migraine
Form
Tablet
Manufacturer
Abbvie Corporation
Drug class
Calcitonin gene-related peptide receptor antagonist
Sold in
Canada
DIN
02533987

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Atogepant pills and guides

What is Atogepant used for?

Atogepant is used for migraine.

Medicine type
Calcitonin gene-related peptide receptor antagonist
Official uses from the US prescribing label

QULIPTA is indicated for the preventive treatment of migraine in adults.

From the FDA-approved label on DailyMed (published Feb 10, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02533987.
  • It names Qulipta, Atogepant 30 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Qulipta by Abbvie Corporation.

In Canada: prescription only.

Ingredients

Active: Atogepant

Other Atogepant pills